blog.aids.gov — HIV Policy & Programs. Research. New Media.
HIV Policy & Programs. Research. New Media.
On Saturday, February 26th, I attended a day-long meeting organized by the Centers for Disease Control and Prevention (CDC) and hosted by the Fenway Community Health Center in Boston. The theme of the meeting was “Moving forward with PrEP Implementation.” Meeting participants included researchers involved in the original iPrEX study and other ongoing HIV prevention…
The President has committed the Federal government to implementing a National HIV/AIDS Strategy (NHAS) that is “grounded in the best science.” Scientific research efforts have greatly expanded our understanding of HIV/AIDS and produced a large number of critical tools and interventions to help us diagnose, prevent, and treat HIV. The past year has been particularly…
Co-authored by Carole Heilman, Ph.D., Director of NIAID’s Division of Microbiology and Infectious Diseases Over the course of the past two decades the National Institute of Allergy and Infectious Diseases (NIAID) has developed an extensive set of networks to conduct clinical trials related to HIV/AIDS. These networks have helped to develop effective treatments for AIDS,…
One of the goals of the National HIV/AIDS Strategy was to refocus existing efforts and deliver better results to the American people within current funding levels, as well as make the case for new investments. The Office of National AIDS Policy (ONAP) is excited to share some of the progress the Obama Administration has made…
Our colleague Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) will appear tonight on "Hope Survives: 30 Years of AIDS," an hour-long special on Anderson Cooper 360° at 9pm ET on CNN. The program will focus on the role stigma continues to play in the spread of HIV, and prevention and…
As the AIDS.gov blog's fourth year begins, we at AIDS.gov are taking time to reflect on 2010 and look to the year ahead. As we continue to integrate monitoring and evaluation into our work, we thought that the New Year provided a nice benchmark to look more closely at our blog. For us, the blog…
Earlier this week the Food and Drug Administration (FDA) announced the approval of the INSTI™ HIV-1 Antibody Test, a new, single use rapid test for the detection of HIV antibodies developed by bioLytical Laboratories of Canada. The newly approved test provides results in as little as 60 seconds, in contrast to the six previously approved…
Every year on December 1, we commemorate World AIDS Day to bring attention to the tremendous impact of the HIV epidemic in the United States and around the world. In observance of World AIDS Day, today CDC launched a special report, CDC Vital Signs on HIV Testing in the United States, in recognition of the…
